AstraZeneca Pharma India Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	5,361	5,056	5,003	4,484	3,523
Cash & Short-Term Investments	3,999	5,361	5,056	5,003	4,484	3,523
Cash Growth	-19.49%	6.05%	1.04%	11.58%	27.27%	39.54%
Accounts Receivable	-	1,849	1,531	1,075	858.9	851.9
Other Receivables	-	143.6	160.4	105.1	121.8	56.6
Receivables	-	1,995	1,693	1,181	981.6	911.2
Inventory	-	5,485	2,279	1,902	1,402	1,598
Prepaid Expenses	-	142.1	109.6	117.7	108.2	83.9
Other Current Assets	-	439.6	190	150.4	80.5	71.1
Total Current Assets	-	13,424	9,327	8,355	7,057	6,188
Property, Plant & Equipment	-	635.8	648.4	701.9	766.9	849.8
Other Intangible Assets	-	6.6	21.1	-	-	-
Long-Term Deferred Tax Assets	-	415.6	212.5	206.7	163	145.3
Other Long-Term Assets	-	698.6	568.5	576.6	574.9	560.1
Total Assets	-	15,181	10,780	9,849	8,566	7,747
Accounts Payable	-	4,563	1,965	2,279	1,904	1,784
Accrued Expenses	-	602.7	767.2	852.3	785.3	736.6
Current Portion of Leases	-	62.8	18.1	35.2	36.1	35.1
Current Income Taxes Payable	-	106.4	66.6	24.2	49.4	56.3
Current Unearned Revenue	-	722.4	490.5	398	306.9	128.3
Other Current Liabilities	-	972.7	263.7	250.8	244.4	295
Total Current Liabilities	-	7,030	3,571	3,839	3,327	3,035
Long-Term Leases	-	294.5	27.8	36.9	50.2	86.3
Pension & Post-Retirement Benefits	-	53.7	44.4	69	48.2	40.8
Other Long-Term Liabilities	-	99.5	17.7	16.6	26.8	23.3
Total Liabilities	-	7,478	3,661	3,962	3,452	3,185
Common Stock	-	50	50	50	50	50
Retained Earnings	-	6,859	6,313	5,088	4,321	3,772
Comprehensive Income & Other	-	795	756.4	749.2	743	739.4
Shareholders' Equity	7,990	7,704	7,119	5,887	5,114	4,562
Total Liabilities & Equity	-	15,181	10,780	9,849	8,566	7,747
Total Debt	347.9	357.3	45.9	72.1	86.3	121.4
Net Cash (Debt)	3,652	5,004	5,010	4,931	4,398	3,402
Net Cash Growth	-23.87%	-0.11%	1.59%	12.13%	29.27%	41.36%
Net Cash Per Share	146.10	200.16	200.39	197.25	175.92	136.08
Filing Date Shares Outstanding	24.99	25	25	25	25	25
Total Common Shares Outstanding	24.99	25	25	25	25	25
Working Capital	-	6,394	5,756	4,515	3,730	3,153
Book Value Per Share	319.63	308.14	284.77	235.48	204.56	182.47
Tangible Book Value	7,990	7,697	7,098	5,887	5,114	4,562
Tangible Book Value Per Share	319.63	307.88	283.92	235.48	204.56	182.47
Land	-	4.9	4.9	4.9	4.9	4.9
Buildings	-	427	427	421.3	415.2	383.4
Machinery	-	1,155	1,208	1,154	1,082	1,023
Construction In Progress	-	-	2.7	13.3	22	40.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.